Zobrazeno 1 - 10
of 215
pro vyhledávání: '"Enbrel®"'
Autor:
Kristina Vollbach, Klaus Tenbrock, Nobert Wagner, Gerd Horneff, Ariane Klein, Ivan Foeldvari, Johannes-Peter Haas, Peer Aries, Georg Gauler, Frank Striesow, Paula Hoff, Christine Scholz, Stefanie Tatsis, Eva Seipelt, Jens Klotsche, Kirsten Minden
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-8 (2022)
Abstract Background To analyze therapy adherence, safety, and outcome in adult patients with juvenile idiopathic arthritis (JIA) treated with the etanercept biosimilar Benepali® (Biogen Inc, Cambridge, USA). Methods Data from the prospective registr
Externí odkaz:
https://doaj.org/article/125441efa6aa4e04b0f9a98fc2bd557f
Autor:
Asim, Muhammad, author
Publikováno v:
Ankylosing Spondylitis and Axial Spondyloarthritis, 2023.
Externí odkaz:
https://doi.org/10.1093/oso/9780198864158.003.0019
Autor:
Daniela Novick
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Human urinary proteins are a goldmine of natural proteins a feature that simplifies their translation to biologics. Combining this goldmine together with the ligand-affinity-chromatography (LAC) purification method, proved a winning formula in their
Externí odkaz:
https://doaj.org/article/1bf573bb25c642688c3b0e4c222823b0
Autor:
Nuria Carballo, Carolina Pérez García, Santiago Grau, Jordi Monfort, Xavier Durán-Jordà, Daniel Echeverría-Esnal, Olivia Ferrández
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Although several randomized clinical trials have confirmed that there is no difference in efficacy between etanercept and its biosimilar versions in the treatment of rheumatoid arthritis (RA), limited real-world evidence is available. We conducted a
Externí odkaz:
https://doaj.org/article/50fe152024be49b7ab243564e0da6217
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Martin Bauer, Edith Lackner, Peter Matzneller, Valentin Al Jalali, Sahra Pajenda, Vincent Ling, Christof Böhler, Werner Braun, Reinhard Braun, Maximilian Boesch, Patrick M. Brunner, Markus Zeitlinger
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Ablative fractional laser treatment facilitates epidermal drug delivery, which might be an interesting option to increase the topical efficacy of biological drugs in a variety of dermatological diseases. This work aims at investigating safety and tol
Externí odkaz:
https://doaj.org/article/35a28d421c484dd4a323a99afeaa73b4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Natalia A. Shushunova, Oksana A. Mayorova, Ekaterina S. Prikhozhdenko, Olga A. Goryacheva, Oleg A. Kulikov, Valentina O. Plastun, Olga I. Gusliakova, Albert R. Muslimov, Olga A. Inozemtseva, Nikolay A. Pyataev, Alexander A. Shirokov, Dmitry A. Gorin, Gleb B. Sukhorukov, Olga A. Sindeeva
Publikováno v:
International Journal of Molecular Sciences
Volume 24
Issue 3
Pages: 2784
Volume 24
Issue 3
Pages: 2784
Complex immunosuppressive therapy is prescribed in medical practice to patients with glomerulonephritis to help them overcome symptoms and prevent chronic renal failure. Such an approach requires long-term systemic administration of strong medication
Gene Expression and Polymorphism of Interleukin-4 in a Sample of Iraqi Rheumatoid Arthritis Patients
Autor:
Baghdad Science Journal
Publikováno v:
Baghdad Science Journal, Vol 15, Iss 2 (2018)
It was aimed to understand the interleukin-4 (IL-4) role in etio-pathogenesis of rheumatoid arthritis (RA). Two approaches were adopted. In the first one, a quantitative expression of IL4 gene was assessed by reverse transcription-quantitative polyme
Externí odkaz:
https://doaj.org/article/60e45f500daf436fabb25d530baf2524
Autor:
Carballo Martínez, Núria, Pérez-García, Carolina, Grau Cerrato, Santiago, Monfort, Jordi, Duran Jordà, Xavier, 1974, Echeverría Esnal, Daniel, Ferrández, Olivia
Publikováno v:
Frontiers in Pharmacology. 13
Although several randomized clinical trials have confirmed that there is no difference in efficacy between etanercept and its biosimilar versions in the treatment of rheumatoid arthritis (RA), limited real-world evidence is available. We conducted a